Filing Details
- Accession Number:
- 0001209191-15-068500
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-28 20:36:32
- Reporting Period:
- 2015-08-26
- Filing Date:
- 2015-08-28
- Accepted Time:
- 2015-08-28 20:36:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1158895 | Lemaitre Vascular Inc | LMAT | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1365741 | R Peter Gebauer | C/O Lemaitre Vascular, Inc. 63 Second Avenue Burlington MA 01803 | President, International Op | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-08-26 | 15,978 | $0.10 | 86,398 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-08-26 | 15,978 | $13.53 | 70,420 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-08-26 | 15,978 | $0.00 | 15,978 | $0.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 81,971 | 1997-06-02 | 2007-06-02 | No | 4 | M | Direct |
Footnotes
- Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $13.41 to $13.69. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- This option is fully vested and exercisable.
- This stock option was originally reported on Form 3 as having an expiration date of June 2, 2007, but does not in fact have an expiration date. Because an expiration date is required to be reported, the originally reported expiration date is included for the sake of consistency.
Billionaire Hedge Funds
